Gedeon Richter UK takes over UK rights to cariprazine
Company strengthens its neuropsychiatry portfolio after marketing transfer from Recordati
Read More
Author: John Pinching
Nxera Pharma reports positive results from phase 3 insomnia trial in South Korea
Company prepares marketing submission after treatment shows strong efficacy
Read More
Scottish Medicines Consortium becomes first in UK to adopt new precision gastric cancer treatment
Decision introduces zolbetuximab for eligible patients in NHS Scotland
Read More
PMGroup Worldwide Ltd welcomes MAD World Summit
Acquisition expands PMGroup’s commitment to transforming workplace health and organisational resilience
Read More
Argenx receives review from FDA for VYVGART in seronegative gMG
Regulator accepts supplemental application supported by positive phase 3 data
Read More- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
